Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ADC Therapeutics (ADCT) Asset Utilization Ratio (2021 - 2026)

ADC Therapeutics has reported Asset Utilization Ratio over the past 6 years, most recently at 0.19 for Q1 2026.

  • Quarterly results put Asset Utilization Ratio at 0.19 for Q1 2026, down 0.74% from a year ago — trailing twelve months through Mar 2026 was 0.19 (down 0.74% YoY), and the annual figure for FY2022 was 0.0, down 100.0%.
  • Asset Utilization Ratio reached 0.19 in Q1 2026 per ADCT's latest filing, up from 0.19 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 163.39 in Q1 2023 and bottomed at 0.12 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.2 (2024), compared with a mean of 43.16.
  • The largest annual shift saw Asset Utilization Ratio soared 507297.27% in 2022 before it plummeted 99.87% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 152.07 in 2022, then fell by 5.7% to 143.4 in 2023, then tumbled by 99.87% to 0.19 in 2024, then grew by 0.5% to 0.19 in 2025, then grew by 2.94% to 0.19 in 2026.
  • Business Quant data shows Asset Utilization Ratio for ADCT at 0.19 in Q1 2026, 0.19 in Q3 2025, and 0.2 in Q2 2025.